Inappropriate empirical antimicrobial therapy for multidrug-resistant organisms in critically ill patients with pneumonia is not an independent risk factor for mortality: Results of a prospective observational study of 758 patients

Journal of Global Antimicrobial Resistance

Volumn 1, Issue 3, 2013, Pages 123-130

  Vasudevan, Anupama ^a   Chuang, Leyland ^b   Jialiang, Li ^c   Mukhopadhyay, Amartya ^a   Goh, Eugene Yu Yuen ^a   Tambyah, Paul A ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibiotic resistance; Critically ill; Inappropriate antibiotic; Mortality; Pneumonia

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIMICROBIAL THERAPY; APACHE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; TRACHEAL ASPIRATION PROCEDURE;

EID: 84882309761     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2013.03.008     Document Type: Article

References (30)

1. T.J. Marrie, and L. Wu Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU Chest 127 2005 1260 1270
2. American Thoracic Society; Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia American Journal of Respiratory and Critical Care Medicine 171 2005 388 416
3. M.J. Fine, H.M. Pratt, D.S. Obrosky, J.R. Lave, L.J. McIntosh, and D.E. Singer Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia American Journal of Medicine 109 2000 378 385
4. A.F. Shorr, N. Haque, C. Taneja, M. Zervos, L. Lamerato, and S. Kothari Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia Journal of Clinical Microbiology 48 2010 3258 3262
5. V.H. Tam, C.A. Rogers, K.-T. Chang, J.S. Weston, J.-P. Caeiro, and K.W. Garey Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes Antimicrobial Agents and Chemotherapy 54 2010 3717 3722
6. H. Burgmann, J.M. Hiesmayr, A. Savey, P. Bauer, B. Metnitz, and P.G.H. Metnitz Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients Intensive Care Medicine 36 2010 1597 1601
7. R. Ramphal Importance of adequate initial antimicrobial therapy Chemotherapy 51 2005 171 176
8. S.-S. Jean, and P.-R. Hsueh High burden of antimicrobial resistance in Asia International Journal of Antimicrobial Agents 37 2011 291 295
9. M.H. Kollef, G. Sherman, S. Ward, and V.J. Fraser Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
10. J.H. Song, and Asian Hospital Acquired Pneumonia Working Group Treatment recommendations of hospital-acquired pneumonia in Asian countries: first consensus report by the Asian HAP Working Group American Journal of Infection Control 36 4 SUPPL.. 2008 S83 S92
11. N. Brusselaers, D. Vogelaers, and S. Blot The rising problem of antimicrobial resistance in the intensive care unit Annals of Intensive Care 1 2011 47
12. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Critical Care Medicine 13 1985 818 829
13. S. Schneeweiss, and M. Maclure Use of comorbidity scores for control of confounding in studies using administrative databases International Journal of Epidemiology 29 2000 891 898
14. S. Morin, J. Tetrault, L. James, J.E. Hopee-Bauer, and M. Pezzlo Specimen acceptability: evaluation of specimen quality H.D. Isenberg, Clinical microbiology procedures handbook 1992 American Society for Microbiology Washington, DC 1.3.1 1.3.6
15. A.-P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clinical Microbiology and Infection 18 2012 268 281
16. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, v.1.0-1.3. EUCAST. http://www.eucast.org/antimicrobial-susceptibility-testing/previous-versions-of- tables/ [accessed 22.03.13].
17. A. Rodriguez, T. Lisboa, S. Blot, I. Martin-Loeches, J. Solé-Violan, and D. De Mendoza Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough Intensive Care Medicine 35 2009 430 438
18. M. Norena, H. Wong, W.D. Thompson, S.P. Keenan, and P.M. Dodek Adjustment of intensive care unit outcomes for severity of illness and comorbidity scores Journal of Critical Care 21 2006 142 150
19. D.P. Raymond, S.J. Pelletier, T.D. Crabtree, H.L. Evans, T.L. Pruett, and R.G. Sawyer Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients Critical Care Medicine 31 2003 1035 1041
20. J.-H. Song, S.-I. Jung, H.K. Ki, M.-H. Shin, K.S. Ko, and J.S. Son Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens Clinical Infectious Diseases 38 2004 1570 1578
21. C.-I. Kang, D.R. Chung, K.S. Ko, K.R. Peck, and J.-H. Song Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli Scandinavian Journal of Infectious Diseases 43 2011 202 208
22. M.-L. Lambert, C. Suetens, A. Savey, M. Palomar, M. Hiesmayr, and I. Morales Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study Lancet Infectious Diseases 11 2011 30 38
23. A.D. Donaldson, L. Razak, L.J. Liang, D.A. Fisher, and P.A. Tambyah Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter? International Journal of Antimicrobial Agents 34 2009 246 251
24. D.H. Kett, E. Cano, A.A. Quartin, J.E. Mangino, M.J. Zervos, and P. Peyrani Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study Lancet Infectious Diseases 11 2011 181 189
25. G. Alvan, C. Edlund, and A. Heddini The global need for effective antibiotics - a summary of plenary presentations Drug Resistance Updates 14 2011 70 76
26. S. Quach, D.A. Hennessy, P. Faris, A. Fong, H. Quan, and C. Doig A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients BMC Health Services Research 9 2009 129
27. P.M. Myrianthefs, M. Kalafati, I. Samara, and G.J. Baltopoulos Nosocomial pneumonia Critical Care Nursing Quarterly 27 2004 241 257
28. S. Magnason, K.G. Kristinsson, T. Stefansson, H. Erlendsdottir, K. Jonsdottir, and M. Kristjansson Risk factors and outcome in ICU-acquired infections Acta Anaesthesiologica Scandinavica 52 2008 1238 1245
29. A. Colpan, E. Akinci, A. Erbay, N. Balaban, and H. Bodur Evaluation of risk factors for mortality in intensive care units: a prospective study from a referral hospital in Turkey American Journal of Infection Control 33 2005 42 47
30. J.C. McGregor, S.E. Rich, A.D. Harris, E.N. Perencevich, R. Osih, and T.P. Lodise A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients Clinical Infectious Diseases 45 2007 329 337